H.R. Hartmann

Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine

Wendy B. Bollag, H.R. Hartmann · European Journal of Cancer (1965) · 1980 · 129 citations

Medicinal Chemistry, Oncology, New Fluorouracil +7

Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes

Werner Rubas, A. Supersaxo, H. G. Weder et al. · International Journal of Cancer · 1986 · 66 citations

Immunology, Unilamellar Liposomes, Lipid Movement +19

5′-O-palmitoyl- and 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine - novel lipophilic analogues of 5′-fluoro-2′-deoxyuridine: Synthesis, incorporation into liposomes and preliminary biological results

R.A. Schwendener, A. Supersaxo, Werner Rubas et al. · Biochemical and Biophysical Research Communications · 1985 · 29 citations

Preliminary Biological Results, Diversity Oriented Synthesis, Bioorganic Chemistry +8

Antiproliferative action of a novel fluorinated uridine analog, 5'-deoxy-5-fluorouridine, measured in vitro and in vivo on four different murine tumor lines.

H.R. Hartmann, Alex Matter · PubMed · 1982 · 20 citations

Uridine Analog, Antiproliferative Action, Same Cell Lines +17

Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778)

Werner Bollag, H.R. Hartmann · European Journal of Cancer and Clinical Oncology · 1987 · 18 citations

Polar End Group, Rat Mammary Carcinogenesis, Chemoprevention Strategy +10